All differentially expressed proteins were downregulated in the cognitive dysfunction group with the exception of Amyloid-like protein-1 (APLP1), a synaptic protein suggested as a biomarker for Alzheimer’s disease, that was significantly increased [24]. The gene discussed is APLP1; the disease is Alzheimer disease.